JOINCARE PHARMACEUTICAL GROUP INDUSTRY CO.,LTD.

Andere Sprachen Joincare Pharmaceutical Group Industry Co.,Ltd.

Aktien

A0M4GR

CNE000001816

600380

Schlusskurs Shanghai S.E. Andere Börsenplätze 00:00:00 28.06.2024			% 5 Tage	% 1. Jan.
11,17 ^CNY	-1,50 %		-6,37 %	-10,14 %

13.06.	China genehmigt Joincare's Anti-Asthma-Medikament	MT
28.05.	China genehmigt Asthma-Medikament von Joincare Unit	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

China Approves Joincare's Anti-Asthma Drug	13.06.
China Approves Joincare Unit's Asthma Drug	28.05.
Joincare Pharmaceutical Group Industry Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	25.04.
Joincare Pharma Says Flu Drug Phase 3 Trial Attains Primary Endpoint	18.04.
Joincare Pharmaceutical Successfully Completes TG-1000 Phase III Study	18.04.
Joincare Pharmaceutical Group's 2023 Profit Falls 4%; Shares Slide 4%	03.04.
Joincare Pharmaceutical Group Industry Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	02.04.
Livzon Pharma to Trial JP-1366 Tablets as Reflux Esophagitis Drug	23.02.
Livzon Pharmaceutical Appoints Former Joincare Exec as Vice President	30.01.
Boan Biotechnology, Joincare Sign Exclusive License Deal for Respiratory Disease Treatment	29.01.
Shandong Boan Biotechnology Co., Ltd. Enters into Agreement with Joincare Pharmaceutical Group Industry Co., Ltd	26.01.
Joincare Pharmaceutical, Guangzhou Fermion Technology Get Nod to Trial Analgesic Drug	12.01.
Livzon Pharmaceutical to Continue Getting Services from Joincare Pharmaceutical	02.01.
Joincare Pharma’s 210 Drugs Included in China's Medical Insurance Catalog	14.12.
Joincare Gets Nod to Trial Pain Relief Drug	05.12.
Joincare Pharma Shortlisted For China’s Drug Procurement Program	07.11.
Tranche Update on Joincare Pharmaceutical Group Industry Co.,Ltd.'s Equity Buyback Plan announced on December 15, 2022.	31.10.23
Joincare Pharmaceutical Group Industry Co.,Ltd.'s Equity Buyback announced on December 15, 2022 has closed with 49,706,643 shares, representing 2.61% for CNY 599.91 million.	27.10.23
Joincare Pharmaceutical Group Industry Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	25.10.23
Joincare Pharma Unit Gets Go Signal from China for Phase 3 Trial of Endometriosis Drug	17.10.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Joincare Pharmaceutical Group Industry Co.,Ltd.

Aktien

A0M4GR

CNE000001816

600380

Andere Sprachen

Filter